TOCQUEVILLE ASSET MANAGEMENT L.P. - CTI BIOPHARMA CORP ownership

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$168,000
+99.7%
40,000
+185.7%
0.00%
+50.0%
Q4 2022$84,14014,0000.00%
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q3 2023.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders